Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Boots parent company to focus on UK as part of cost-saving programme

Boots' parent company has announced plans to “improve operational performance” in the UK, as part of a $1 billion global cost-saving programme.

Walgreens Boots Alliance announced plans for a three-year programme – which will aim to save $1bn annually by the end of its third year – alongside its latest financial results, which also showed a 35% year-on-year drop in Boots UK’s adjusted operating income.

When asked by C+D whether the programme would result in pharmacy closures or staff redundancies in the UK, the parent company said it could not comment further on the announcement.

It has begun a 16-week “assessment phase” to review the company’s costs, with a focus on US and UK markets, as part of a three-year global programme to “simplify our operations and reduce the cost of running the business”, it said last month.

“At the end of that 16 weeks, we will have enormous transparency and granularity. We will know who spends on what, down to the lowest level,” the company's global chief financial officer James Kehoe said during a conference call with analysts to discuss the financial results.

The company will start to roll out the savings programme “immediately” after the 16-week assessment, Mr Kehoe said.

“Need to modernise our customer preposition”

Co-chief operating officer and president of Walgreens Boots Alliance Alex Gourlay said that, while Boots is “strongly positioned in the UK”, it “recognised the need to modernise our customer proposition”.

Boots has “started work on this already”, by “looking to shift where we invest”, focusing on new products and propositions, and “digitalising the whole beauty experience”, Mr Gourlay said.

“All that we are doing fits into an overall plan in developing our offering and the structure to offer materially enhanced, focused and over, time, more personalised and bespoke services to each and every one of our customers,” he added.

“Countering trading pressures”

Stefano Pessina, Walgreens Boots Alliance executive chairman and chief executive officer, said: “A key part of preparing for the future is establishing the right cost based structure and infrastructure for the business as we look to the future in an increasingly automated and digitised world.”

“We believe the transformation programme…has the capacity to counter the trading pressure we are facing in a number of our markets,” he added.

In 2016, Boots cut 700 jobs in the UK, including head office and finance staff. No store-based pharmacists were affected by the redundancies.

A C+D investigation last year also revealed the multiple closed 22 branches in England since the funding cuts came into force, although it insisted this was “usual practice”.

What do you make of Walgreens Boots Alliance's cost-saving programme?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD005684

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel